Laura Edgerly-Pflug

60 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Will Lewis	M	55	INSMED INCORPORATED	12 years
Al Altomari	M	65	INSMED INCORPORATED	12 years
W. Smith	M	68	LYRA THERAPEUTICS, INC.	5 years
C. Merrifield	F	73	LYRA THERAPEUTICS, INC.	5 years
David McGirr	M	69	INSMED INCORPORATED	11 years
Konstantin Poukalov	M	40	LYRA THERAPEUTICS, INC.	4 years
S. Schaeffer	F	55	INSMED INCORPORATED	12 years
Walter R. Perkins	M	-	INSMED INCORPORATED	14 years
Vineeta Belanger	M	-	LYRA THERAPEUTICS, INC.	5 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
R. Elsey	M	71	LYRA THERAPEUTICS, INC.	2 years
Donald Hayden	M	68	INSMED INCORPORATED	9 years
Christine Pellizzari	F	56	INSMED INCORPORATED	8 years
Timothy G. Whitten	M	67	INSMED INCORPORATED	2 years
Nicholas Lee Gurreri	M	-	INSMED INCORPORATED	-
Andrea Holtzman Drucker	F	66	INSMED INCORPORATED	2 years
Peter M. Clarke	M	64	INSMED INCORPORATED	-
Dee Grosso	F	-	INSMED INCORPORATED	-
Richard Kollender	M	54	INSMED INCORPORATED	2 years
Robert Richard	M	-	LYRA THERAPEUTICS, INC.	3 years
Kevin P. Tully	M	70	INSMED INCORPORATED	6 years
Geoffrey Allan	M	70	INSMED INCORPORATED	10 years
Graham K. Crooke	M	65	INSMED INCORPORATED	11 years
Matthew Pauls	M	53	INSMED INCORPORATED	1 years
Dana Washburn	M	61	LYRA THERAPEUTICS, INC.	1 years
Renu Gupta	M	68	INSMED INCORPORATED	4 years
Philip Young	M	66	INSMED INCORPORATED	3 years
Stephen Glover	M	60	INSMED INCORPORATED	4 years
Denny Lanfear	M	68	INSMED INCORPORATED	3 years
Kenneth G. Condon	M	76	INSMED INCORPORATED	11 years
Ronald D. Gunn	M	63	INSMED INCORPORATED	9 years
Nicholas LaBella	M	68	INSMED INCORPORATED	2 years
Jane M. Maida	F	68	Adgero Biopharmaceuticals Holdings, Inc. Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ.	-
Andrew Drechsler	M	52	INSMED INCORPORATED	5 years
Thomas Keuer	M	65	INSMED INCORPORATED	2 years
Wesley H. Kaupinen	M	-	INSMED INCORPORATED	-
Kenneth Attie	M	67	INSMED INCORPORATED	3 years

Statistics

Country	Connections	% of total
United States	36	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections